Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SKRR to Commence Uranium Drill Program to Test Conductors at Clearwater West (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Medipharm Labs Corp MEDIF


Primary Symbol: T.LABS

Healthcare Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

Recent & Breaking News (TSX:LABS)

MediPharm Labs Appoints Renowned Cannabis Researcher Dr. Landolt-Marticorena, MD, PhD, to its Science Advisory Committee

GlobeNewswire August 20, 2019

MediPharm Labs Reports Strong, Profitable Second Quarter Results

GlobeNewswire August 12, 2019

MediPharm Labs Sets Date to Announce Second Quarter 2019 Financial Results

GlobeNewswire August 1, 2019

MediPharm Labs Announces Trading Date on the Toronto Stock Exchange

GlobeNewswire July 25, 2019

MediPharm Labs Conditionally Approved to Graduate to the TSX

GlobeNewswire July 18, 2019

MediPharm Labs Provides Operational Update and Increases Average Weekly Production of Active Cannabinoid Component to 75 Million Milligrams

GlobeNewswire July 16, 2019

OTC Markets Group Announces Quarterly Index Performance and Rebalancing

PR Newswire July 11, 2019

MediPharm Labs Secures 9,000 KG of Dried Cannabis Adding Substantial Private Label Cannabis Extract Production

GlobeNewswire June 27, 2019

MediPharm Labs Receives Permits and Ships First Medical Cannabis Concentrate to Australia

GlobeNewswire June 24, 2019

MediPharm Labs and Ace Valley Enter Vape Oil White Label Deal

GlobeNewswire June 19, 2019

MediPharm Labs Announces Application to Upgrade Listing to the Toronto Stock Exchange

GlobeNewswire June 18, 2019

MediPharm Labs Announces Closing of $75 Million Bought Deal Financing

GlobeNewswire June 17, 2019

Live Investor Conference & Webinar June 20th

PR Newswire June 14, 2019

Extracts Supply Demand Heightens with Surging Alternative Cannabis Markets

Press Releases June 6, 2019

IIROC Trading Resumption - LABS

Canada NewsWire May 29, 2019

MediPharm Labs Corp. Announces Upsize of Bought Deal Financing to $75 Million

GlobeNewswire May 29, 2019

MediPharm Labs Announces $60 Million Bought Deal Equity Financing

GlobeNewswire May 28, 2019

IIROC Trading Halt - LABS

Canada NewsWire May 28, 2019

UPDATE - New York City Icahn School of Medicine at Mount Sinai and Renowned Global Researcher Dr. Hurd, Select MediPharm Labs to Support 500 Patient Major Clinical Study And "CBD International Consortium" to Develop Treatment of Opioid Addiction

GlobeNewswire May 23, 2019

IIROC Trading Resumption - LABS

Canada NewsWire May 22, 2019